Selpacta
Selpercatinib
- Concentración
- 40mg/80mg
- Fabricante
- Ziska Pharma
- Disponibilidad
- Disponible para obtener
Selpercatinib 40mg/80mg — Capsule, 30's Pot / 60's Pot
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Retevmo by LOXO ONCOLOGY · Manufacturer: Ziska Pharma. Indication & Dosage: Selpacta (Selpercatinib), generic Retevmo is a prescription medicine used to treat certain types of cancer such as non-small cell lung cancer (NSCLC), advanced thyroid cancer, advanced medullary thyroid cancer (MTC) in patients whose tumors have RET fusion-positive genes. Selpercatinib works by slowing or stopping the growth of cancer cells. Selpacta manufactured by Ziska pharma Ltd. In Bangladesh. Selpercatinib has to take orally twice (every 12 hours) daily with/ without food. Side Effects: The most common adverse reactions of Selpercatinib are: Dry mouth , diarrhea , constipation , headache , cough, swelling ankles/feet, nausea, vomiting, or fatigue . The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
